Cardio Diagnostics Holdings, Inc.
CDIO- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001870144
No open-market purchases or sales by Cardio Diagnostics Holdings, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $422.7K in total; no superinvestor holds it.
Other share classesCDIOW
Q4 2023 vs. Q3 2023
How the institutions holding Cardio Diagnostics Holdings, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 15 | 14 | −1 |
| Shares | 450.7K | 1.66M | +1.21M (+267.4%) |
| Value | $152.4K | $4.12M | +$3.97M (+2,606.6%) |
New holders (5)
Institutions that held Cardio Diagnostics Holdings, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock Inc. | 1,067,062 | $2.66M | 0.00% |
| Northern Trust Corp | 46,106 | $114.8K | 0.00% |
| Squarepoint Ops LLC | 39,105 | $97.4K | 0.00% |
| Vontobel Holding Ltd. | 12,000 | $30.1K | 0.00% |
| Advisor Group Holdings, Inc. | 500 | $1.25K | 0.00% |
Sold out (6)
Institutions that held Cardio Diagnostics Holdings, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Prelude Capital Management, LLC | 121,000 | $41.1K |
| Two Sigma Securities, LLC | 32,245 | $11.0K |
| Renaissance Technologies LLC | 17,800 | $6.00K |
| HRT Financial LP | 11,273 | $3.00K |
| UBS Group AG | 61 | $21 |
| JPMorgan Chase & Co | 6 | $2 |